SCHEMBL7813624

SCHEMBL7813624

CC(C)OC(=O)C(C)(C)Oc1cccc(C2=CCN(C(=O)c3ccc(C(F)(F)F)cc3)CC2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
ALOX15 P16050 1/20 0.40
MAPT P10636 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
CCR2 P41597 1/20 0.39
NAMPT P43490 3/20 0.38
SLC6A7 Q99884 1/20 0.38
LMNA P02545 4/20 0.38
GAA P10253 1/20 0.38
SOS1 Q07889 1/20 0.37
PPARG P37231 3/20 0.37
PPARA Q07869 3/20 0.37
HPGD P15428 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 2/20 0.37
ALDH1A1 P00352 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7814015 0.91 NAMPT (0.44) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7804444 0.91 NAMPT (0.44) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7817469 0.90 NAMPT (0.44) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7813905 0.90 ALDH1A1 (0.46) POLBALOX15MAPTSMN1; SMN2NAMPT
SCHEMBL7811486 0.90 PPARG (0.49) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7809885 0.90 POLB (0.41) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7817528 0.90 NAMPT (0.49) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7811498 0.88 PPARA (0.47) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7804294 0.85 HPGD (0.39) POLBALOX15MAPTSMN1; SMN2MMP2
SCHEMBL7813597 0.84 HPGD (0.39) POLBALOX15MAPTSMN1; SMN2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed